Neil M Carleton

22PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Neil Carleton, Alexander C Chang, Fangyuan Chen

|Sep 02, 2025
Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Neil Carleton, Alexander C Chang, Fangyuan Chen

|Jun 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy.

Dong Hu, Xiaoshuang Lyu, Zheqi Li

|Jun 19, 2025
Reciprocal immune-epithelial interaction during breast cancer induction.

Neil Carleton, Michael T Lotze

|Jun 09, 2025
Overdiagnosis, competing morbidity and tumour biology in older women with breast cancer: building a case for active monitoring.

Neil Carleton, Priscilla F McAuliffe

|Mar 03, 2025
CITEgeist: Cellular Indexing of Transcriptomes and Epitopes for Guided Exploration of Intrinsic Spatial Trends.

Alexander Chih-Chieh Chang, Brent T Schlegel, Neil Carleton

Pageof 4

Frequent Collaborators

12 joint publications

Adrian V Lee

10 joint publications

Steffi Oesterreich

3 joint publications

Zheqi Li

3 joint publications

Alexander Chih-Chieh Chang